Tying claim against CVS could affect Aetna deal, observers say

As the Department of Justice reviews CVS Health’s $69 billion purchase of Aetna, a healthcare information technology company has sued the pharmacy chain and benefit manager for allegedly forcing the plaintiff’s customers to use its subsidiary Wellpartner’s services in violation of federal antitrust laws.

Get unlimited access to all Global Competition Review content